← Leaderboards
Hazem E. Ghoneim
Ohio State University
$1,920,168
Attributed
$1,920,168
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $640.1K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,920,168 · 1
By mechanism
R01$1,920,168 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Shujun Liu$5,854,035
- Natarajan Muthusamy$5,466,792
- Pan Zheng$7,391,253
- Charis Eng$16,046,725
- Hannah Choe$1,022,976
Others in their field
Other Rising Stars on “Adoptive Transfer”
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
- Torben Schiffner · Vanderbilt University$3,383,634
- John-Paul F Navarro · University Of Illinois At Urbana-Champaign$3,377,803
- Winona Snapp-Childs · University Of Illinois At Urbana-Champaign$3,377,803
Research focus
Adoptive TransferAgonistAntagonistBackBiological ModelsBreast AdenocarcinomaCancer PatientCd8-Positive T-LymphocytesCell PhysiologyCellsChromatinChromatin RemodelingChronicChronic InfectionCrispr/Cas TechnologyCtla4 GeneCytotoxicCytotoxic Cd8 T CellsDna MethylationDnmt3aEffectivenessEndowmentEnzymesAcceleration
Grant awards (3)
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming$640,056
R01 · FY2025 · AI · contact PI
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming$640,056
R01 · FY2024 · AI · contact PI
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming$640,056
R01 · FY2023 · AI · contact PI